Clinical trial
OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation
NCT00439127 · Oncology Institute of Southern Switzerland, Other · Completed
Key facts
| NCT number | NCT00439127 |
|---|---|
| Title | OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation |
| Official title | Is the Thyroglobulin Measurement Under Thyroxine of Prognostic Value Before rhTSH-Aided Radioiodine Ablation in Differentiated Thyroid Carcinoma? |
| Lead sponsor | Oncology Institute of Southern Switzerland, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Differentiated Thyroid Carcinoma |
| Enrollment | 28 |
| Start date | Jan 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Feb 23, 2007 |
| Last update posted | Feb 28, 2007 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: